GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kuros Biosciences Ltd (LTS:0RHR) » Definitions » Pre-Tax Income

Kuros Biosciences (LTS:0RHR) Pre-Tax Income : CHF-7.37 Mil (TTM As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Kuros Biosciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Kuros Biosciences's pretax income for the six months ended in Jun. 2024 was CHF1.10 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-7.37 Mil. Kuros Biosciences's pretax margin was 3.44%.

During the past 13 years, Kuros Biosciences's highest Pretax Margin was -14.03%. The lowest was -4048.61%. And the median was -1186.39%.


Kuros Biosciences Pre-Tax Income Historical Data

The historical data trend for Kuros Biosciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuros Biosciences Pre-Tax Income Chart

Kuros Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.82 -12.09 -9.55 -15.99 -13.35

Kuros Biosciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.52 -11.47 -4.88 -8.47 1.10

Competitive Comparison of Kuros Biosciences's Pre-Tax Income

For the Medical Devices subindustry, Kuros Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kuros Biosciences's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kuros Biosciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kuros Biosciences's Pre-Tax Income falls into.



Kuros Biosciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kuros Biosciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-13.192+0+-0.186+0.4+-0.369
=-13.35

Kuros Biosciences's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.559+0+-0.434+2.089+2.2204460492503E-16
=1.10

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-7.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kuros Biosciences  (LTS:0RHR) Pre-Tax Income Explanation

Kuros Biosciences's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=1.096/31.844
=3.44%

During the past 13 years, Kuros Biosciences's highest Pretax Margin was -14.03%. The lowest was -4048.61%. And the median was -1186.39%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kuros Biosciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Kuros Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Kuros Biosciences Business Description

Traded in Other Exchanges
Address
Wagistrasse 25, Schlieren, Zurich, CHE, 8952
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

Kuros Biosciences Headlines

No Headlines